Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Horvath

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|February 27, 2021
Reply to: "Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation"Philipp Horvath, Can Yurttas
Langenbeck'S Archives of Surgery|January 14, 2023
Reply to "Letter to the Editor on Yurttas C et al. Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis"Can Yurttas, Alfred Königsrainer, Philipp Horvath
Chirurgie (Heidelberg, Germany)|August 20, 2022
[Current status of surgical treatment of peritoneal metastases from colorectal cancer]Can Yurttas, Markus W Löffler, Alfred Königsrainer, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|September 8, 2016
Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritoneiPhilipp Horvath, Stefan Beckert, Florian Struller, et al.
Langenbeck'S Archives of Surgery|December 4, 2018
Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyPhilipp Horvath, Can Yurttas, Philipp Birk, et al.
Journal of Gastric Cancer|July 26, 2014
Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastasesIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Cancers|June 2, 2021
Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary TumorsPhilipp Horvath, Can Yurttas, Stefan Beckert, et al.
Langenbeck'S Archives of Surgery|February 3, 2022
Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasisCan Yurttas, Lisa Überrück, Giorgi Nadiradze, et al.
Clinical & Experimental Metastasis|August 1, 2018
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancerPhilipp Horvath, Stefan Beckert, Florian Struller, et al.
Pleura and Peritoneum|June 15, 2019
Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomenTorben Glatz, Philipp Horvath, Sven A Lang, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|February 27, 2021
Reply to: "Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation"Philipp Horvath, Can Yurttas
Langenbeck'S Archives of Surgery|January 14, 2023
Reply to "Letter to the Editor on Yurttas C et al. Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasis"Can Yurttas, Alfred Königsrainer, Philipp Horvath
Chirurgie (Heidelberg, Germany)|August 20, 2022
[Current status of surgical treatment of peritoneal metastases from colorectal cancer]Can Yurttas, Markus W Löffler, Alfred Königsrainer, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|September 8, 2016
Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritoneiPhilipp Horvath, Stefan Beckert, Florian Struller, et al.
Langenbeck'S Archives of Surgery|December 4, 2018
Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyPhilipp Horvath, Can Yurttas, Philipp Birk, et al.
Journal of Gastric Cancer|July 26, 2014
Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastasesIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Cancers|June 2, 2021
Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary TumorsPhilipp Horvath, Can Yurttas, Stefan Beckert, et al.
Langenbeck'S Archives of Surgery|February 3, 2022
Limitations of laparoscopy to assess the peritoneal cancer index and eligibility for cytoreductive surgery with HIPEC in peritoneal metastasisCan Yurttas, Lisa Überrück, Giorgi Nadiradze, et al.
Clinical & Experimental Metastasis|August 1, 2018
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancerPhilipp Horvath, Stefan Beckert, Florian Struller, et al.
Pleura and Peritoneum|June 15, 2019
Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomenTorben Glatz, Philipp Horvath, Sven A Lang, et al.
Pageof 4